Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Two Investigational OTC Eye Drops in Healthy Adults With Red Eye
NCT03198000Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tetryzoline in ocular redness (3 arms), sponsored by Johnson & Johnson. Primary endpoints: Clinician Assessment of Change From Baseline in Redness at 60 Seconds After First Product Application and Percentage of Participants With Response to Redness at 60 Seconds After First Product Application. Started Jun 2017; status: completed.
02
Drugs
tetryzoline
03
Conditions
ocular redness
Beyond the preview
Go deeper on NCT03198000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03198000.